What’s News in Markets: Amgen’s Prognosis, Quantum Boost, iPhone Makeover
Summary
WSJ’s Imani Moise reviews a volatile week where inflation fears and the Iran conflict pushed oil above $100 and 10-year Treasury yields near 5%, causing broad stock declines. Healthcare stocks, particularly Amgen and Novartis, suffered after a failed heart disease trial raised doubts about Lp(a) treatments. Meanwhile, quantum computing firms rallied on federal investment, and Apple shares recovered after its $1,999 foldable iPhone Duo launch.
Topics discussed
Sponsor: ReliaQuest Agent Defense AI
Intro: Market overview and inflation pressures
Bond yields, Fed expectations, and weekly index performance
Healthcare sector drop: Novartis trial failure and Amgen impact
Quantum computing stocks rally on federal investment
Government tech investments: Intel and Fluidstack loan
Quantum stock performance and Apple iPhone Duo price reveal
Apple foldable phone analysis and stock reaction
Apple supplier gains and weekly market wrap-up
Sponsor: David Booth's book 'Stay Calm'
Listen ad-free on Castria